Corporate News     17-Apr-17
Unichem Laboratories receives ANDA approval for Piroxicam Capsules
From USFDA
Unichem Laboratories has received ANDA approval from the United States Food and Drug Administration (USFDA) for Piroxicam Capsules USP 10mg & 20mg, which are therapeutically equivalent to Feldene Capsules 10mg & 20mg of Pfizer, Inc. Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID) indicated for relief of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA). For the relief of rheumatoid arthritis and osteoarthritis, the dosage is 20 mg given orally once daily. If desired, the daily dose may be divided. Usually lowest effective dosage for the shortest duration, consistent with individual patient treatment goals is recommended. The product will be commercialized from Unichem's Goa plant. Active Pharmaceutical Ingredient will also be made in house at Roha API Plant.
Previous News
  Unichem Laboratories fixes record date for dividend
 ( Market Beat - Reports 28-Jun-22   12:11 )
  Unichem Laboratories reports consolidated net loss of Rs 0.41 crore in the March 2021 quarter
 ( Results - Announcements 29-May-21   15:18 )
  Unichem Laboratories receives USFDA approval for Guanfacine Tablets
 ( Corporate News - 04-Mar-21   17:30 )
  Unichem Laboratories reports standalone net profit of Rs 0.86 crore in the March 2021 quarter
 ( Results - Announcements 29-May-21   15:10 )
  Unichem Laboratories receives ANDA approval for Atenolol and Chlorthalidone Tablets
 ( Corporate News - 30-Nov-20   13:13 )
  Unichem Laboratories reports consolidated net loss of Rs 22.21 crore in the September 2019 quarter
 ( Results - Announcements 04-Nov-19   13:31 )
  Unichem Laboratories receives 4 observation for its Goa facility
 ( Corporate News - 31-Jul-19   18:33 )
  Unichem Lab receives ANDA approval for Divalproex Sodium ER tablets
 ( Corporate News - 28-Feb-22   12:33 )
  Unichem Labs sizzles after securing USFDA nod
 ( Hot Pursuit - 12-Dec-18   09:41 )
  Unichem Laboratories net profit rises 144.42% in the December 2013 quarter
 ( Results - Announcements 18-Jan-14   15:52 )
  Outcome of board meeting of Unichem Laboratories
 ( Corporate News - 13-May-14   17:10 )
Other Stories
  Board of Delhivery approves alteration in capital clause of MoA
  05-Jul-24   19:32
  J B Chemicals & Pharmaceuticals appoints director
  05-Jul-24   19:30
  Infosys announces resignation of senior management personnel
  05-Jul-24   19:22
  JLR Q1 FY25 retail sales up 9% on YoY basis
  05-Jul-24   19:08
  Bajaj Auto launches world's first CNG motorcycle 'Freedom'
  05-Jul-24   18:59
  Agenda for board meeting of Power Grid Corporation of India
  05-Jul-24   18:46
  Board of Bank of Baroda approves raising additional capital up to Rs 7,500 cr in FY25
  05-Jul-24   18:06
  Vipul to hold board meeting
  05-Jul-24   17:15
  Markobenz Ventures to convene board meeting
  05-Jul-24   17:15
  Dhanashree Electronics to declare Quarterly Result
  05-Jul-24   17:15
Back Top